Fuan Pharmaceutical Group Co (300194) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.023x

Based on the latest financial reports, Fuan Pharmaceutical Group Co (300194) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥100.27 Million ≈ $14.67 Million USD) by net assets (CN¥4.45 Billion ≈ $651.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300194 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Fuan Pharmaceutical Group Co - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Fuan Pharmaceutical Group Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Fuan Pharmaceutical Group Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fuan Pharmaceutical Group Co ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Great Lakes Dredge & Dock NASDAQ:GLDD	0.098x
Ningbo Bohui Chemical Technology SHE:300839	-0.134x
Hubei Sanxia New Building Materials Co Ltd SHG:600293	-0.007x
Diversified Royalty Corp TO:DIV	0.043x
Guangdong Piano Customized Furniture Co Ltd SHE:002853	0.016x
Shenzhen Sunwin Intelligent SHE:300044	-0.017x
Zhejiang Xinao Textiles Inc SHG:603889	0.064x
Start Group SHG:600734	-0.075x

Annual Cash Flow Conversion Efficiency for Fuan Pharmaceutical Group Co (2007–2024)

The table below shows the annual cash flow conversion efficiency of Fuan Pharmaceutical Group Co from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 300194 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.40 Billion ≈ $643.58 Million	CN¥303.59 Million ≈ $44.42 Million	0.069x	-12.95%
2023-12-31	CN¥4.15 Billion ≈ $607.09 Million	CN¥328.98 Million ≈ $48.14 Million	0.079x	-7.82%
2022-12-31	CN¥3.95 Billion ≈ $577.49 Million	CN¥339.50 Million ≈ $49.68 Million	0.086x	+29.34%
2021-12-31	CN¥3.87 Billion ≈ $565.70 Million	CN¥257.13 Million ≈ $37.63 Million	0.067x	+86.38%
2020-12-31	CN¥4.56 Billion ≈ $666.55 Million	CN¥162.55 Million ≈ $23.79 Million	0.036x	-51.84%
2019-12-31	CN¥3.99 Billion ≈ $583.77 Million	CN¥295.63 Million ≈ $43.26 Million	0.074x	+2.27%
2018-12-31	CN¥3.69 Billion ≈ $540.55 Million	CN¥267.68 Million ≈ $39.17 Million	0.072x	-33.34%
2017-12-31	CN¥4.17 Billion ≈ $610.29 Million	CN¥453.37 Million ≈ $66.34 Million	0.109x	+15.16%
2016-12-31	CN¥3.96 Billion ≈ $580.00 Million	CN¥374.16 Million ≈ $54.75 Million	0.094x	+25.23%
2015-12-31	CN¥2.14 Billion ≈ $312.59 Million	CN¥161.03 Million ≈ $23.56 Million	0.075x	+511.64%
2014-12-31	CN¥1.71 Billion ≈ $249.86 Million	CN¥-31.27 Million ≈ $-4.58 Million	-0.018x	-135.25%
2013-12-31	CN¥1.72 Billion ≈ $252.41 Million	CN¥89.61 Million ≈ $13.11 Million	0.052x	+42.41%
2012-12-31	CN¥1.72 Billion ≈ $251.77 Million	CN¥62.77 Million ≈ $9.18 Million	0.036x	-4.80%
2011-12-31	CN¥1.69 Billion ≈ $247.66 Million	CN¥64.85 Million ≈ $9.49 Million	0.038x	-89.82%
2010-12-31	CN¥281.05 Million ≈ $41.13 Million	CN¥105.74 Million ≈ $15.47 Million	0.376x	-2.08%
2009-12-31	CN¥163.31 Million ≈ $23.90 Million	CN¥62.75 Million ≈ $9.18 Million	0.384x	-13.55%
2008-12-31	CN¥110.76 Million ≈ $16.21 Million	CN¥49.23 Million ≈ $7.20 Million	0.444x	-80.47%
2007-12-31	CN¥8.31 Million ≈ $1.22 Million	CN¥18.92 Million ≈ $2.77 Million	2.276x	--

About Fuan Pharmaceutical Group Co

SHE:300194 China Drug Manufacturers - Specialty & Generic

Market Cap

$609.32 Million

CN¥4.16 Billion CNY

Market Cap Rank

#11396 Global

#3254 in China

Share Price

CN¥3.50

Change (1 day)

-0.85%

52-Week Range

CN¥3.50 - CN¥5.02

All Time High

CN¥10.53